Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)

Total article views   HTML views PDF downloads Totals
11,691 Dovepress* 10,082+ 2,208 12,290
PubMed Central* 1,609 1,371 2,980
Totals 11,691 3,579 15,270
*Since 25 July 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar